Isolated pelvic perfusion in treatment for malignant tumors

Yastrebov, I.P.; Surov, D.A.; Belyaev, A.M.; Demko, A.E.; Soloviev, I.A.; Kandyba, D.V.; Gafton, G.I.; Senchik, K.Y.; Kireeva, G.S.; Musii, G.V.; Kirillov, D.A.; Vasilchenko, M.M.; Zenin, A.M.; Falevko, S.Y.; Yastrebov, I.P; Surov, D.A; Belyaev, A.M; Demko, A.E; Soloviev, I.A; Kandyba, D.V; Gafton, G.I; Senchik, K.Y; Kireeva, G.S; Musii, G.V; Kirillov, D.A; Vasilchenko, M.M; Zenin, A.M; Falevko, S.Y

Home

>

Node

>

Subnode

Isolated pelvic perfusion in treatment for malignant tumors

Yastrebov, I.P.; Surov, D.A.; Belyaev, A.M.; Demko, A.E.; Soloviev, I.A.; Kandyba, D.V.; Gafton, G.I.; Senchik, K.Y.; Kireeva, G.S.; Musii, G.V.; Kirillov, D.A.; Vasilchenko, M.M.; Zenin, A.M.; Falevko, S.Y.

Voprosy Onkologii 62(3): 379-389

2016

ISSN/ISBN: 0507-3758

PMID: 30462898

Document Number: 685885

Rationale and feasibility of isolated pelvic perfusion (IPP) as a high-tech treatment modality for patients with pelvic malignancies was studied and analyzed based on the systematic review of the literature. Indications, techniques and regimens of IPP are reviewed. There is a focus on anticancer agents for IPP and methods of complete vascular isolation of the perfusated region. Data on the short- and long-term outcome of patients after IPP are presented. To the best of authors' knowledge this is the first Russian article regarding application of IPP in oncology practice.